CTRI/2017/03/007996Other未知
Efficacy and safety of SPILs Rifaximin tablets, 200 mg Rifaximin in subjects with travelers diarrhea : A Randomized, Double blind, Parallel group, Active and Placebo Controlled, Clinical Endpoint Bio equivalence Study
试验速览
- 阶段
- 未知
- 状态
- Other
- 入组人数
- 1
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Willing to participate and give written informed consent.
- •2.Able and willing to comply with the protocol, including availability for all scheduled clinic visits.
- •3.woman of child bearing potential - having a negative urine pregnancy test prior to beginning the therapy and ready to use effective contraceptive methods during the study.
- •4.Experiencing at least three unformed stools recorded within the 24 hours
排除标准
- •1.Pregnant, breast feeding or planning a pregnancy.
- •2.Having active, uncontrolled, or clinically significant diseases
- •3.Use of any drug such as aspirin or ibuprofen, which can cause GI bleeding
研究者
相似试验
招募中
不适用
Efficacy and safety of Rifaximin for the treatment of liver cirrhosis with covert hepatic encephalopathyiver cirrhosisJPRN-UMIN000044657Wakayama Medical University40
已完成
2 期
Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE)Overt Hepatic EncephalopathyNCT03515044Bausch Health Americas, Inc.71
进行中（未招募）
1 期
Phase II clinical trial, conducted in different sites, with random assignation of treatment, where neither the patient or the medical doctor know the assigned treatment, drug or placebo, to evaluate the efficacy and safety of Rifaximin delayed release 400 mg tablet in Patients with Moderate-to-Severe Papulopustular Rosacea and Positive Lactulose Breath TestModerate-to-Severe Papulopustular Rosacea and Positive Lactulose Breath TestMedDRA version: 20.0Level: PTClassification code 10076537Term: Papulopustular rosaceaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2017-003722-33-ITALFASIGMA S.P.A.236
进行中（未招募）
1 期
Phase II clinical trial, conducted in different sites, with random assignation of treatment, where neither the patient or the medical doctor know the assigned treatment, drug or placebo, to evaluate the efficacy and safety of Rifaximin delayed release 400 mg tablet in Patients with Moderate-to-Severe Papulopustular RosaceaEUCTR2017-003722-33-DEALFASIGMA S.P.A.228
尚未招募
Unknown
The effect of Rifaximin (an antibiotic drug commonly used in liver failure patients) and standard medical therapy vs standard medical therapy alone on myosteatosis (fat deposition in abdominal muscles), in patients with decompensated cirrhosis- a randomized controlled trialCTRI/2024/07/069984PGIMER, CHANDIGARH